These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 16532541)
1. New drug to treat rare leukemia and lymphoma. FDA Consum; 2006; 40(1):4-5. PubMed ID: 16532541 [No Abstract] [Full Text] [Related]
2. Nelarabine (Arranon) for T-cell acute lymphoblastic leukemia. Med Lett Drugs Ther; 2006 Feb; 48(1228):14-5. PubMed ID: 16467734 [No Abstract] [Full Text] [Related]
3. Nelarabine induced complete remission in an adult with refractory T-lineage acute lymphoblastic leukemia: A case report and review of the literature. Sigalas P; Tourvas AD; Moulakakis A; Pangalis G; Kontopidou F Leuk Res; 2009 Jul; 33(7):e61-3. PubMed ID: 19157550 [No Abstract] [Full Text] [Related]
4. FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma. Cohen MH; Johnson JR; Justice R; Pazdur R Oncologist; 2008 Jun; 13(6):709-14. PubMed ID: 18586926 [TBL] [Abstract][Full Text] [Related]